Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 August 2006, Vol. 108, No. 4, pp. 1402-1405.
Prepublished online as a Blood First Edition Paper on March 30, 2006; DOI 10.1182/blood-2006-02-003376.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-02-003376v1
108/4/1402    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lesbordes-Brion, J.-C.
Right arrow Articles by Vaulont, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lesbordes-Brion, J.-C.
Right arrow Articles by Vaulont, S.
Related Collections
Right arrow Red Cells
Right arrow Brief Reports
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

RED CELLS
Brief report

Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis

Jeanne-Claire Lesbordes-Brion, Lydie Viatte, Myriam Bennoun, Dan-Qing Lou, Guillemette Ramey, Christophe Houbron, Ghislaine Hamard, Axel Kahn, and Sophie Vaulont

From the Institut Cochin, Département de Génétique, Développement et Pathologie Moléculaire; Institut National de la Santé et de la Recherche Médicale (INSERM) U567; Centre National de la Recherche Scientifique (CNRS); and Université Paris Descartes, Faculté de Médecine René Descartes, Paris, France.

We previously reported that mice made deficient for the transcriptional factor USF2 fail to express hepcidin 1 and hepcidin 2 genes as a consequence of targeted disruption of the Usf2 gene lying just upstream in the locus. These mice developed an iron overload phenotype with excess iron deposition in parenchymal cells and decreased reticuloendothelial iron. At that time, although the role of USF2 was still confounding, we proposed for the first time the role of hepcidin as a negative regulator of iron absorption and iron release from macrophages. Accordingly, we subsequently demonstrated that hyperexpression of hepcidin 1, but not hepcidin 2, resulted in a profound hyposideremic anemia. To analyze the consequences of hepcidin 1 deletion on iron metabolism without any disturbance due to USF2 deficiency, we disrupted the hepcidin 1 gene by targeting almost all the coding region. Confirming our prior results, Hepc1–/– mice developed early and severe multivisceral iron overload, with sparing of the spleen macrophages, and demonstrated increased serum iron and ferritin levels as compared with their controls.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. W. Lee, S. Rajagopalan, A. Siddiq, R. Gwiazda, L. Yang, M. F. Beal, R. R. Ratan, and J. K. Andersen
Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity: MODEL FOR THE POTENTIAL INVOLVEMENT OF THE HYPOXIA-INDUCIBLE FACTOR PATHWAY IN PARKINSON DISEASE
J. Biol. Chem., October 16, 2009; 284(42): 29065 - 29076.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Peslova, J. Petrak, K. Kuzelova, I. Hrdy, P. Halada, P. W. Kuchel, S. Soe-Lin, P. Ponka, R. Sutak, E. Becker, et al.
Hepcidin, the hormone of iron metabolism, is bound specifically to {alpha}-2-macroglobulin in blood
Blood, June 11, 2009; 113(24): 6225 - 6236.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Kautz, D. Meynard, A. Monnier, V. Darnaud, R. Bouvet, R.-H. Wang, C. Deng, S. Vaulont, J. Mosser, H. Coppin, et al.
Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver
Blood, August 15, 2008; 112(4): 1503 - 1509.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. C. Andrews
Forging a field: the golden age of iron biology
Blood, July 15, 2008; 112(2): 219 - 230.
[Full Text] [PDF]


Home page
ASH Education BookHome page
M. D. Fleming
The Regulation of Hepcidin and Its Effects on Systemic and Cellular Iron Metabolism
Hematology, January 1, 2008; 2008(1): 151 - 158.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020